in vivo , prazosin modified the range of cacl2 arrhythmias , reduced the mean control sinus rate ( by 21.7 % at 1 mg/kg ) , reduced incidence and mortality by ventricular fibrillation and lengthened survival time of animals that eventually died .
C0003811
arrhythmias
C0042510
ventricular